Cell and molecular biology underpinning the effects of PEDF on cancers in general and osteosarcoma in particular

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Chandolu, Vijay ^a   Dass, Crispin R ^a  

^a VICTORIA UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; CHECKPOINT KINASE 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HYPOXIA INDUCIBLE FACTOR 1; MATRIGEL; MATRIX METALLOPROTEINASE; PIGMENT EPITHELIUM DERIVED FACTOR; THROMBOSPONDIN 1; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; CANCER GROWTH; CANCER INHIBITION; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; DNA DAMAGE; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE FUSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEUROBLASTOMA; NICK END LABELING; NONHUMAN; OSTEOSARCOMA; REVIEW; TUMOR DIFFERENTIATION; WESTERN BLOTTING; ANIMAL; BLOOD; BONE TUMOR; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; EYE PROTEINS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTORS; OSTEOSARCOMA; SERPINS;

EID: 84862299043     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/740295     Document Type: Review

References (62)

1. Cancer Society American,. 2010, http://www.cancer.org/Research/ CancerFactsFigures/CancerFactsFigures/index
2. Ek E. T. H., Dass C. R., Choong P. F. M., Pigment epithelium-derived factor: a multimodal tumor inhibitor Molecular Cancer Therapeutics 2006 5 7 1641 1646 (Pubitemid 44323231)
3. Ek E. T. H., Dass C. R., Choong P. F. M., PEDF: a potential molecular therapeutic target with multiple anti-cancer activities Trends in Molecular Medicine 2006 12 10 497 502 (Pubitemid 44468197)
4. Murray A. R., Ma J. X., PEDF as a treatment for cervical cancer Cancer Biology and Therapy 2010 9 12 975 977
5. Broadhead M. L., Dass C. R., Choong P. F., In vitro and in vivo biological activity of PEDF against a range of tumors Expert Opinion on Therapeutic Targets 2009 13 12 1429 1438
6. Yang J., Duh E. J., Caldwell R. B., Ali Behzadian M., Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/ -catenin signaling pathway and uPAR expression Investigative Ophthalmology and Visual Science 2010 51 6 3273 3280
7. Halin S., Wikstrm P., Rudolfsson S. H., Stattin P., Doll J. A., Crawford S. E., Bergh A., Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors Cancer Research 2004 64 16 5664 5671 (Pubitemid 39095563)
8. Uehara H., Miyamoto M., Kato K., Ebihara Y., Kaneko H., Hashimoto H., Murakami Y., Hase R., Takahashi R., Mega S., Shichinohe T., Kawarada Y., Itoh T., Okushiba S., Kondo S., Katoh H., Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma Cancer Research 2004 64 10 3533 3537 (Pubitemid 38657928)
9. Matsumoto K., Ishikawa H., Nishimura D., Hamasaki K., Nakao K., Eguchi K., Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma Hepatology 2004 40 1 252 259 (Pubitemid 38868944)
10. Abramson L. P., Stellmach V., Doll J. A., Cornwell M., Arensman R. M., Crawford S. E., Ford H., Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model Journal of Pediatric Surgery 2003 38 3 336 342 (Pubitemid 36278689)
11. Tombran-Tink J., Mazuruk K., Rodriguez I. R., Chung D., Linker T., Englander E., Chader G. J., Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Molecular Vision 1996 2 11
12. Patricia Becerra S., Focus on molecules: pigment epithelium-derived factor (PEDF) Experimental Eye Research 2006 82 5 739 740 (Pubitemid 43170874)
13. Yasui N., Mori T., Morito D., Matsushita O., Kourai H., Nagata K., Koide T., Dual-site recognition of different extracellular matrix components by anti-angiogenic/neurotrophic serpin, PEDF Biochemistry 2003 42 11 3160 3167 (Pubitemid 36348624)
14. Volpert O. V., Zaichuk T., Zhou W., Reiher F., Ferguson T. A., Stuart P. M., Amin M., Bouck N. P., Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor Nature Medicine 2002 8 4 349 357 (Pubitemid 34407029)
15. Zaichuk T. A., Shroff E. H., Emmanuel R., Filleur S., Nelius T., Volpert O. V., Nuclear factor of activated T cells balances angiogenesis activation and inhibition Journal of Experimental Medicine 2004 199 11 1513 1522 (Pubitemid 38780406)
16. Ho T. C., Chen S. L., Yang Y. C., Liao C. L., Cheng H. C., Tsao Y. P., PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells Cardiovascular Research 2007 76 2 213 223
17. Zhang T., Guan M., Xu C., Chen Y., Lu Y., Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo Life Sciences 2007 81 16 1256 1263 (Pubitemid 47539504)
18. Dawson D. W., Volpert O. V., Gillis P., Crawford S. E., Xu H. J., Benedict W., Bouck N. P., Pigment epithelium-derived factor: a potent inhibitor of angiogenesis Science 1999 285 5425 245 248 (Pubitemid 29329995)
19. Hanahan D., Folkman J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 1996 86 3 353 364 (Pubitemid 26272076)
20. Maik-Rachline G., Shaltiel S., Seger R., Extracellular phosphorylation converts pigment epithelium-derived factor from a neurotrophic to an antiangiogenic factor Blood 2005 105 2 670 678 (Pubitemid 40070751)
21. Castellanos A., Vicente-Dueas C., Campos-Snchez E., Cruz J. J., Garca-Criado F. J., Garca-Cenador M. B., Lazo P. A., Pérez-Losada J., Snchez-Garca I., Cancer as a reprogramming-like disease: Implications in tumor development and treatment Seminars in Cancer Biology 2010 20 2 93 97
22. Sharma S. V., Bell D. W., Settleman J., Haber D. A., Epidermal growth factor receptor mutations in lung cancer Nature Reviews Cancer 2007 7 3 169 181
23. Ji L., Roth J. A., Tumor suppressor FUS1 signaling pathway Journal of Thoracic Oncology 2008 3 4 327 330 (Pubitemid 351489470)
24. Croce C. M., Oncogenes and cancer New England Journal of Medicine 2008 358 5 502 511 (Pubitemid 351185806)
25. Travasso R. D. M., Poiré E. C., Castro M., Rodrguez-Manzaneque J. C., Hernndez-Machado A., Tumor angiogenesis and vascular patterning: a mathematical model PLoS One 2011 6 5
26. Jones E. A. V., Le Noble F., Eichmann A., What determines blood vessel structure? Genetic prespecification vs. hemodynamics Physiology 2006 21 6 388 395 (Pubitemid 44879247)
27. Forsythe J. A., Jiang B. H., Iyer N. V., Agani F., Leung S. W., Koos R. D., Semenza G. L., Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 Molecular and Cellular Biology 1996 16 9 4604 4613 (Pubitemid 26272112)
28. Yancopoulos G. D., Davis S., Gale N. W., Rudge J. S., Wiegand S. J., Holash J., Vascular-specific growth factors and blood vessel formation Nature 2000 407 6801 242 248
29. Jain R. K., Molecular regulation of vessel maturation Nature Medicine 2003 9 6 685 693 (Pubitemid 36749217)
30. Choi J. W., Kim S., Kim T. M., Kim Y. M., Seo H. W., Park T. S., Jeong J. W., Song G., Han J. Y., Basic fibroblast growth factor activates MEK/ERK cell signaling pathway and stimulates the proliferation of chicken primordial germ cells PLoS One 2010 5 9
31. Thurston G., Complementary actions of VEGF and Angiopoietin-1 on blood vessel growth and leakage Journal of Anatomy 2002 200 6 575 580 (Pubitemid 34823049)
32. Heldin C. H., Westermark B., Mechanism of action and in vivo role of platelet-derived growth factor Physiological Reviews 1999 79 4 1283 1316 (Pubitemid 29473317)
33. Ren B., Yee K. O., Lawler J., Khosravi-Far R., Regulation of tumor angiogenesis by thrombospondin-1 Biochimica et Biophysica Acta 2006 1765 2 178 188
34. Sheahan S., Bellamy C. O., Harland S. N., Harrison D. J., Prost S., TGFbeta induces apoptosis and EMT in primary mouse hepatocytes independently of p53, p21Cip1 or Rb status BMC Cancer 2008 8, article no. 191
35. O'Reilly M. S., Holmgren L., Shing Y., Chen C., Rosenthal R. A., Moses M., Lane W. S., Cao Y., Sage E. H., Folkman J., Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 1994 79 2 315 328 (Pubitemid 24324921)
36. Paek S. Y., Kim Y. S., Choi S. G., The orientation-dependent expression of angiostatin-endostatin hybrid proteins and their characterization for the synergistic effects of antiangiogenesis Journal of Microbiology and Biotechnology 2010 20 10 1430 1435
37. Medema R. H., Macrek L., Checkpoint recovery in cells: how a molecular understanding can help in the fight against cancer F1000 Biology Reports 2011 3 1, article no. 10
38. Hengartner M. O., The biochemistry of apoptosis Nature 2000 407 6805 770 776
39. Gu C., Zhang J., Chen Y., Lei J., A trigger model of apoptosis induced by tumor necrosis factor signaling BMC Systems Biology 2011 5 1, article no. 13
40. Gupta G. P., Massagué J., Cancer metastasis: building a framework Cell 2006 127 4 679 695 (Pubitemid 44781029)
41. Zhang S. X., Wang J. J., Gao G., Parke K., Ma J. X., Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy Journal of Molecular Endocrinology 2006 37 1 1 12 (Pubitemid 44288601)
42. Yang L. P., Cheng P., Peng X. C., Shi H. S., He W. H., Cui F. Y., Luo S. T., Wei Y. Q., Yang L., Anti-tumor effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma Journal of Experimental and Clinical Cancer Research 2009 28 1, article no. 75
43. Abe R., Shimizu T., Yamagishi S. I., Shibaki A., Amano S., Inagaki Y., Watanabe H., Sugawara H., Nakamura H., Takeuchi M., Imaizumi T., Shimizu H., Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo American Journal of Pathology 2004 164 4 1225 1232 (Pubitemid 38387789)
44. Garcia M., Fernandez-Garcia N. I., Rivas V., Carretero M., Escamez M. J., Gonzalez-Martin A., Medrano E. E., Volpert O., Jorcano J. L., Jimenez B., Larcher F., Del Rio M., Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor Cancer Research 2004 64 16 5632 5642 (Pubitemid 39095559)
45. Jeong A., Lee H. J., Jeong S. J., Lee H. J., Lee E. O., Bae H., Kim S. H., Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells Biological and Pharmaceutical Bulletin 2010 33 6 945 950
46. Quan G. M., Ojaimi J., Choong P. F., Cartilage-derived anti-angiogenic therapy for osteosarcoma: a novel approach International Journal of Cancer Prevention 2004 1 411 419
47. Quan G. M. Y., Ojaimi J., Li Y., Kartsogiannis V., Zhou H., Choong P. F. M., Localization of pigment epithelium-derived factor in growing mouse bone Calcified Tissue International 2005 76 2 146 153 (Pubitemid 40684962)
48. Lord E. A., Martin S. K., Gray J. P., Li C., Clark D. E., Cell cycle genes PEDF and CDKN1C in growing Deer antlers Anatomical Record 2007 290 8 994 1004
49. Akiyama T., Dass C. R., Shinoda Y., Kawano H., Tanaka S., Choong P. F. M., PEDF regulates osteoclasts via osteoprotegerin and RANKL Biochemical and Biophysical Research Communications 2010 391 1 789 794
50. Quan G. M. Y., Ojaimi J., Nadesapillai A. P. W., Zhou H., Choong P. F. M., Resistance of epiphyseal cartilage to invasion by osteosarcoma is likely to be due to expression of antiangiogenic factors Pathobiology 2002 70 6 361 367 (Pubitemid 36829012)
51. Ek E. T. H., Dass C. R., Contreras K. G., Choong P. F. M., Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis Cancer Gene Therapy 2007 14 7 616 626 (Pubitemid 46912035)
52. Ek E. T. H., Dass C. R., Contreras K. G., Choong P. F. M., Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor Clinical and Experimental Metastasis 2007 24 2 93 106 (Pubitemid 46669247)
53. Dass C. R., Ek E. T., Contreras K. G., Choong P. F., A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma Clinical and Experimental Metastasis 2006 23 7-8 367 380 (Pubitemid 46197119)
54. Broadhead M. L., Dass C. R., Choong P. F. M., Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model British Journal of Cancer 2011 105 10 1503 1511
55. Tan M. L., Choong P. F. M., Dass C. R., Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion Biochemical and Biophysical Research Communications 2010 398 4 613 618
56. Ladhani O., Snchez-Martinez C., Orgaz J. L., Jimenez B., Volpert O. V., Pigment epithelium-derived factor blocks tumor extravasation by suppressing amoeboid morphology and mesenchymal proteolysis1,2 Neoplasia 2011 13 7 633 642
57. Crawford S. E., Stellmach V., Ranalli M., Huang X., Huang L., Volpert O., De Vries G. H., Abramson L. P., Bouck N., Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity Journal of Cell Science 2001 114 24 4421 4428 (Pubitemid 34082862)
58. Cheung L. W. T., Au S. C. L., Cheung A. N. Y., Ngan H. Y. S., Tombran-Tink J., Auersperg N., Wong A. S. T., Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells Endocrinology 2006 147 9 4179 4191 (Pubitemid 44268369)
59. Hase R., Miyamoto M., Uehara H., Kadoya M., Ebihara Y., Murakami Y., Takahashi R., Mega S., Li L., Shichinohe T., Kawarada Y., Kondo S., Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice Clinical Cancer Research 2005 11 24 8737 8744 (Pubitemid 43005924)
60. Ek E. T. H., Dass C. R., Contreras K. G., Choong P. F. M., PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma Journal of Orthopaedic Research 2007 25 12 1671 1680 (Pubitemid 350293816)
61. Mirochnik Y., Aurora A., Schulze-Hoepfner F. T., Deabes A., Shifrin V., Beckmann R., Polsky C., Volpert O. V., Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth Clinical Cancer Research 2009 15 5 1655 1663
62. Dittmer S., Sahin M., Pantlen A., Saxena A., Toutzaris D., Pina A. L., Geerts A., Golz S., Methner A., The constitutively active orphan G-protein-coupled receptor GPR39 protects from cell death by increasing secretion of pigment epithelium-derived growth factor Journal of Biological Chemistry 2008 283 11 7074 7081